{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:27:27Z","timestamp":1783481247119,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Australas Phys Eng Sci Med"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s13246-018-0658-3","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T08:04:02Z","timestamp":1529913842000},"page":"747-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radioiodine (131I) therapies performed in a paediatric hospital: facilities and procedures"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-2599","authenticated-orcid":false,"given":"Giovanni","family":"Bibbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Benger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sigalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"key":"658_CR1","unstructured":"Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) (2002) Recommendations: discharge of patients undergoing treatment with radioactive substances. Radiation protection series no. 4. Yallambie. https:\/\/www.arpansa.gov.au . Accessed 6 Sept"},{"key":"658_CR2","unstructured":"Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) (2012) Results of the Quality Assurance Testing Program for Radiopharmaceuticals (2011). Technical Report 159 619, Yallambie. ISSN 0157\u20131400. https:\/\/www.arpansa.gov.au . Accessed 6 Sept"},{"key":"658_CR3","first-page":"171","volume":"87","author":"RS Benua","year":"1962","unstructured":"Benua RS, Cicale NR, Sonenberg M, Rawson RW (1962) The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med 87:171\u2013182","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"658_CR4","volume-title":"Principles of nuclear medicine","author":"WH Beierwaltes","year":"1969","unstructured":"Beierwaltes WH, Wagner HN Jr, Vought RL, Masi AT (1969) The thyroid gland. In: Wagner Jr HN (ed) Principles of nuclear medicine. W B Saunders Company. Philadelphia"},{"key":"658_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/oxfordjournals.rpd.a080346","volume":"25","author":"GT Peng","year":"1988","unstructured":"Peng GT, Tseng CL, Tung CJ, Yang CP, Wang IL (1988) Assessment of beta particle dose for radioactive contamination on skin. Radiat Prot Dosimetry 25:15\u201319. https:\/\/doi.org\/10.1093\/oxfordjournals.rpd.a080346","journal-title":"Radiat Prot Dosimetry"},{"key":"658_CR6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1677\/ERC-09-0076","volume":"16","author":"H H\u00e4nscheid","year":"2009","unstructured":"H\u00e4nscheid H, Lassmann M, Luster M, Kloos RT, Reiners C (2009) Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 16:1283\u20131289","journal-title":"Endocr Relat Cancer"},{"key":"658_CR7","unstructured":"National Health and Medical Research Council (NHMRC) (1995) Recommended limits on radioactive contamination on surfaces in laboratories: radiation health series number 38. Australian Government Publishing Service, Canberra"},{"issue":"3","key":"658_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/HP.0000000000000210","volume":"108","author":"D D\u2019Alessio","year":"2015","unstructured":"D\u2019Alessio D, Giliberti C, Benassi M, Strigari L (2015) Potential third-party radiation exposure from patients undergoing therapy with 131I for thyroid cancer or metastases. Health Phys 108(3):319\u2013325","journal-title":"Health Phys"},{"key":"658_CR9","first-page":"1241","volume":"43","author":"JA Siegel","year":"2002","unstructured":"Siegel JA, Marcus CS, Sparks RB (2002) Calculating the absorbed dose from radioactive patients: the line-source versus point source model. J Nucl Med 43:1241\u20131244","journal-title":"J Nucl Med"},{"issue":"6","key":"658_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/01.HP.0000275298.69543.5c","volume":"93","author":"J Willegaignon","year":"2007","unstructured":"Willegaignon J, Guimar\u00e3es MIC, Stabin MG, Sapienza MT, Malvestiti LF, Marone MM, Sordi G-MA (2007) Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models. Health Phys 93(6):678\u2013688","journal-title":"Health Phys"},{"issue":"2","key":"658_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/HP.0b013e3181eacf38","volume":"100","author":"AB Carvalho de Jr","year":"2011","unstructured":"de Carvalho AB Jr, Stabin MG, Siegel JA, Hunt J (2011) Comparison of point, line and volume dose calculations for exposure to nuclear medicine therapy patients. Health Phys 100(2):185\u2013190","journal-title":"Health Phys"},{"issue":"1","key":"658_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/HP.0000000000000294","volume":"109","author":"YC Liu","year":"2015","unstructured":"Liu YC, Lee KW, Sheu RJ (2015) Comparing dose rates near a radioactive patient evaluated using various source models: point, line, cylinder and anthropomorphic phantoms. Health Phys 109(1):69\u201377","journal-title":"Health Phys"},{"key":"658_CR13","doi-asserted-by":"crossref","unstructured":"Cristy M (1980) Mathematical phantoms representing children of various ages for use in estimates of internal dose. NUREG\/CR-1159 ORNL\/NUREG\/TM-367, Oak Ridge National Laboratory, Oak Ridge, TN","DOI":"10.2172\/5308345"},{"issue":"3","key":"658_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/BF03178671","volume":"27","author":"S Woodings","year":"2004","unstructured":"Woodings S (2004) Radiation protection recommendations for I-131 thyrotoxicosis, thyroid cancer and phaeochromacytoma patients. Australia Phys Eng Sci Med 27(3):118\u2013128","journal-title":"Australia Phys Eng Sci Med"},{"key":"658_CR15","doi-asserted-by":"crossref","unstructured":"International Commission on Radiological Protection (ICRP) (1987) Radiation dose to patients from radiopharmaceuticals. ICRP Publication 53 Ann ICRP 18(1\u20134)","DOI":"10.1016\/0146-6453(87)90003-0"},{"key":"658_CR16","doi-asserted-by":"publisher","DOI":"10.4103\/wjnm.WJNM_40_18","author":"G Bibbo","year":"2018","unstructured":"Bibbo G, Kirkwood I, Sigalas V, Benger T (2018) Radioiodine therapy (131I) in a child with autism spectrum disorder: a complex and demanding task. World J Nucl Med. https:\/\/doi.org\/10.4103\/wjnm.WJNM_40_18","journal-title":"World J Nucl Med"}],"container-title":["Australasian Physical & Engineering Sciences in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13246-018-0658-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13246-018-0658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13246-018-0658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T18:03:13Z","timestamp":1720375393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13246-018-0658-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1007\/s13246-018-0658-3","relation":{},"ISSN":["0158-9938","1879-5447"],"issn-type":[{"value":"0158-9938","type":"print"},{"value":"1879-5447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,25]]},"assertion":[{"value":"22 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}